MMP9 and osteosarcoma: In the present study, the MMP-inhibitor Marimastat significantly inhibited osteosarcoma cell invasion, which suggest that MMPs are vital factor in osteosarcoma invasion, and that risedronate suppressed the expressions of MMP-2 and MMP-9.